Authorization announcementNo.: CN1171617c.
Announcement date of authorization: 2004. 10.20
ApplicationNo.: 02 1256470
Date of application: July 26, 2002
Patent holder: Wei Yanzhe; ? Zhao Xia
Inventor: Wei Dianzhen; ? Wei Yanzhe
Address: Xinrong Jiayuan, Asian Games Village, Chaoyang District, Beijing 1000 12 A-5g
Classification number: a 61k 35/78; ? A6 1P 19/08 All
Domestic priority: 021168334 April 2002.10cn
abstract:
The invention relates to a traditional Chinese medicine for treating cervical spondylosis, which is characterized by comprising 50- 160 parts of roasted myrrh, 25-80 parts of calcined pyritum, 30-95 parts of Massa Medicata Fermentata, 15-50 parts of Eupolyphaga Seu Steleophaga, 10-40 parts of notoginseng and 75-240 parts. 180-600 parts of prepared nux vomica and 50- 150 parts of roasted frankincense. Making into capsules according to the conventional method. It has the effects of promoting blood circulation, removing blood stasis, dredging meridians, regulating liver and tonifying kidney, and eliminating exogenous pathogenic wind, cold and dampness. The treatment of cervical spondylosis has the advantages of short course of treatment, quick response, low cost, no side effects, no risk, no pain and no recurrence.